Abstract: The present disclosure relates to a process for manufacturing at least one sartan active compound of formula (I) wherein R is selected from a group of formulas (1), (2), (3), (4) and (5), comprising the tetrazolylation of one compound of formula (II) wherein R is as previously defined, in a reactional medium with at least one azide derivative, wherein benzylic azide impurities formed during said tetrazolylation are converted into aldehyde derivatives.
| # | Name | Date |
|---|---|---|
| 1 | 202417033420-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [26-04-2024(online)].pdf | 2024-04-26 |
| 2 | 202417033420-STATEMENT OF UNDERTAKING (FORM 3) [26-04-2024(online)].pdf | 2024-04-26 |
| 3 | 202417033420-REQUEST FOR EXAMINATION (FORM-18) [26-04-2024(online)].pdf | 2024-04-26 |
| 4 | 202417033420-FORM 18 [26-04-2024(online)].pdf | 2024-04-26 |
| 5 | 202417033420-FORM 1 [26-04-2024(online)].pdf | 2024-04-26 |
| 6 | 202417033420-DECLARATION OF INVENTORSHIP (FORM 5) [26-04-2024(online)].pdf | 2024-04-26 |
| 7 | 202417033420-COMPLETE SPECIFICATION [26-04-2024(online)].pdf | 2024-04-26 |
| 8 | 202417033420-FORM-26 [28-06-2024(online)].pdf | 2024-06-28 |
| 9 | 202417033420-Proof of Right [19-09-2024(online)].pdf | 2024-09-19 |
| 10 | 202417033420-FORM 3 [22-10-2024(online)].pdf | 2024-10-22 |